{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:38:27Z","timestamp":1791412707230,"version":"4.3.3"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.<\/jats:p>","DOI":"10.1093\/ehjci\/jex146","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T07:07:57Z","timestamp":1494918477000},"page":"1073-1089","source":"Crossref","is-referenced-by-count":114,"title":["A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation &amp; Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology"],"prefix":"10.1093","volume":"18","author":[{"name":"Writing group:","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H J A","family":"Slart","sequence":"additional","affiliation":[{"name":"1Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands"},{"name":"2Department of Biomedical Photonic Imaging, University of Twente, Enschede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor W J M","family":"Glaudemans","sequence":"additional","affiliation":[{"name":"1Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[{"name":"3Department of Cardiology, GIGA-Cardiovascular Sciences, University Hospital Sart Tilman, Li\u00e8ge, Belgium"},{"name":"4Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Hyafil","sequence":"additional","affiliation":[{"name":"5Department of Nuclear Medicine, Centre Hospitalier Universitaire Bichat, D\u00e9partement Hospitalo-Universitaire FIRE, Inserm 1148, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 Paris Diderot, Paris, France"},{"name":"6Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Blankstein","sequence":"additional","affiliation":[{"name":"7Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G","family":"Schwartz","sequence":"additional","affiliation":[{"name":"8Cardiology Division, Department of Medicine, University of Rochester Medical Center, Box 679, Rochester, NY, USA"},{"name":"9Nuclear Medicine Division, Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A","family":"Jaber","sequence":"additional","affiliation":[{"name":"10Cleveland Clinic Lerner College of Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Russell","sequence":"additional","affiliation":[{"name":"11Cardiovascular Institute, Rhode Island Hospital, Alpert School of Medicine of Brown University, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Gimelli","sequence":"additional","affiliation":[{"name":"12 Fondazione Toscana\/CNR Gabriele Monasterio, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Rouzet","sequence":"additional","affiliation":[{"name":"5Department of Nuclear Medicine, Centre Hospitalier Universitaire Bichat, D\u00e9partement Hospitalo-Universitaire FIRE, Inserm 1148, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 Paris Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[{"name":"13Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[{"name":"14Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, Belgium and Department of Imaging and Pathology, KU Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Plein","sequence":"additional","affiliation":[{"name":"15Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J","family":"Miller","sequence":"additional","affiliation":[{"name":"16Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[{"name":"7Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Donal","sequence":"additional","affiliation":[{"name":"17Service de Cardiologie, et CIC-IT INSERM 1414, - CHU Rennes, - Rennes, France"},{"name":"18LTSI, Universit\u00e9 de Rennes 1 - INSERM, UMR 1099, - Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Document reading group:","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sciagra","sequence":"additional","affiliation":[{"name":"19Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bucerius","sequence":"additional","affiliation":[{"name":"20Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands"},{"name":"21Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands"},{"name":"22Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein J","family":"Verberne","sequence":"additional","affiliation":[{"name":"23Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Lindner","sequence":"additional","affiliation":[{"name":"24Institute of Radiology, Nuclear Medicine and Molecular Imaging, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"\u00dcbleis","sequence":"additional","affiliation":[{"name":"25Department of Clinical Radiology, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Agostini","sequence":"additional","affiliation":[{"name":"26Department of Nuclear Medicine, CHU Cote de Nacre, CAEN, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Signore","sequence":"additional","affiliation":[{"name":"27Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, \u2018Sapienza\u2019 University of Roma, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Edvardsen","sequence":"additional","affiliation":[{"name":"28Department of Cardiology, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Neglia","sequence":"additional","affiliation":[{"name":"12 Fondazione Toscana\/CNR Gabriele Monasterio, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S","family":"Beanlands","sequence":"additional","affiliation":[{"name":"29Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Di Carli","sequence":"additional","affiliation":[{"name":"7Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[{"name":"30Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasken","family":"Dilsizian","sequence":"additional","affiliation":[{"name":"31Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Soman","sequence":"additional","affiliation":[{"name":"32Division of Cardiology, Heart and Vascular Institute, University of Pittsburgh Medical Center, A-429 Scaife Hall, 200 Lothrop Street, Pittsburgh, PA, 15213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Habib","sequence":"additional","affiliation":[{"name":"33Department of Cardiology, Aix-Marseille Universit\u00e9, Marseille 13284, France La Timone Hospital, 13005, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EACVI Reviewers: This document was reviewed by members of the EACVI Scientific Documents Committee for 2014\u20132016 and 2016\u20132018:","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Cardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cosyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Flachskampf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Haugaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giorgio","family":"Masci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"2026080919292062500_jex146-B1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of Sarcoidosis 1946-2013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2026080919292062500_jex146-B2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080919292062500_jex146-B3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"2026080919292062500_jex146-B4","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"2026080919292062500_jex146-B5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2026080919292062500_jex146-B6","first-page":"178","article-title":"Sarcoidosis presenting as heart disease","volume":"13","author":"Nelson","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026080919292062500_jex146-B7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"Kim","year":"2009","journal-title":"Am Heart J"},{"key":"2026080919292062500_jex146-B8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026080919292062500_jex146-B9","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Jpn Ministry Health Welfare","year":"2007","journal-title":"Jpn J Sarcoidosis and Granulomatuous Disord (Japanese)"},{"key":"2026080919292062500_jex146-B10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080919292062500_jex146-B11","doi-asserted-by":"crossref","first-page":"280.","DOI":"10.1093\/ehjci\/jeu291","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association","volume":"16","author":"Cardim","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjci\/jeu128","article-title":"European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease","volume":"16","author":"Cosyns","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ehjci\/jeu015","article-title":"Recommendations for transoesophageal echocardiography: EACVI update 2014","volume":"15","author":"Flachskampf","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jer316","article-title":"EAE\/ASE recommendations for image acquisition and display using three-dimensional echocardiography","volume":"13","author":"Lang","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2011.01.015","article-title":"Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese","volume":"24","author":"Mor-Avi","year":"2011","journal-title":"Society of Echocardiography. J Am Soc Echocardiogr"},{"key":"2026080919292062500_jex146-B18","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/ehjci\/jeu057","article-title":"Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging: an executive summary. Eur","volume":"15","author":"Popescu","year":"2014","journal-title":"Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B19","first-page":"949","article-title":"Advances in imaging for diagnosis and management of cardiac sarcoidosis","volume":"16","author":"Aggarwal","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00296-009-0904-9","article-title":"Assessment of cardiac involvement in sarcoidosis by echocardiography","volume":"29","author":"Focardi","year":"2009","journal-title":"Rheumatol Int"},{"key":"2026080919292062500_jex146-B21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-8703(85)90524-1","article-title":"Echocardiographic evaluation of patients with systemic sarcoidosis","volume":"110","author":"Lewin","year":"1985","journal-title":"Am Heart J"},{"key":"2026080919292062500_jex146-B22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026080919292062500_jex146-B23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026080919292062500_jex146-B24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.4960131014","article-title":"Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis","volume":"13","author":"Jain","year":"1990","journal-title":"Clin Cardiol"},{"key":"2026080919292062500_jex146-B25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/echo.13163","article-title":"Right heart involvement in patients with sarcoidosis","volume":"33","author":"Patel","year":"2016","journal-title":"Echocardiography"},{"key":"2026080919292062500_jex146-B26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1540-8167.2008.01351.x","article-title":"Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia","volume":"20","author":"Vasaiwala","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919292062500_jex146-B27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/crj.12307","article-title":"Myocardial deformation and total atrial conduction time in the prediction of cardiac involvement in patients with pulmonary sarcoidosis","volume":"11","author":"Degirmenci","year":"2017","journal-title":"Clin Respir J"},{"key":"2026080919292062500_jex146-B28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080919292062500_jex146-B29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00408-014-9586-5","article-title":"Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis","volume":"192","author":"Kul","year":"2014","journal-title":"Lung"},{"key":"2026080919292062500_jex146-B30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.echo.2015.02.018","article-title":"Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac sarcoidosis: comparison with magnetic resonance imaging","volume":"28","author":"Orii","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919292062500_jex146-B31","doi-asserted-by":"crossref","first-page":"1275.","DOI":"10.1093\/ehjci\/jev189","article-title":"Cardiac sarcoidosis with visually normal wall motion: role of cardiac MRI, FDG PET, and strain echocardiography","volume":"16","author":"Saeed","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00408-015-9748-0","article-title":"Early detection of bi-ventricular and atrial mechanical dysfunction using two-dimensional speckle tracking echocardiography in patients with sarcoidosis","volume":"193","author":"Tigen","year":"2015","journal-title":"Lung"},{"key":"2026080919292062500_jex146-B33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/hrt.2003.027763","article-title":"Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation","volume":"90","author":"Hyodo","year":"2004","journal-title":"Heart"},{"key":"2026080919292062500_jex146-B34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2004.05.028","article-title":"Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter","volume":"102","author":"Yasutake","year":"2005","journal-title":"Int J Cardiol"},{"key":"2026080919292062500_jex146-B35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mje.2001.110785","article-title":"Transesophageal echocardiographic abnormalities in a case of cardiac sarcoidosis","volume":"14","author":"Hourigan","year":"2001","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919292062500_jex146-B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1536\/ihj.13-243","article-title":"Interventricular septal thickening as an early manifestation of cardiac sarcoidosis","volume":"55","author":"Nureki","year":"2014","journal-title":"Int Heart J"},{"key":"2026080919292062500_jex146-B37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1253\/jcj.62.465","article-title":"Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: clinical utility of radionuclide imaging for differential diagnosis","volume":"62","author":"Yazaki","year":"1998","journal-title":"Jpn Circ J"},{"key":"2026080919292062500_jex146-B38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2796.2002.01058.x","article-title":"Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography","volume":"252","author":"Skold","year":"2002","journal-title":"J Intern Med"},{"key":"2026080919292062500_jex146-B39","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1136\/hrt.2011.226076","article-title":"Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment","volume":"97","author":"Youssef","year":"2011","journal-title":"Heart"},{"key":"2026080919292062500_jex146-B40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1540-8167.2008.01417.x","article-title":"The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities","volume":"20","author":"Soejima","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919292062500_jex146-B41","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B42","first-page":"1571","article-title":"Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis","volume":"47","author":"Nishiyama","year":"2006","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.acra.2014.01.008","article-title":"The role of 18F-FDG-PET and PET\/CT in patients with sarcoidosis: an updated evidence-based review","volume":"21","author":"Treglia","year":"2014","journal-title":"Acad Radiol"},{"key":"2026080919292062500_jex146-B44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292062500_jex146-B46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.110.952184","article-title":"Images in cardiovascular medicine: Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case","volume":"122","author":"Koiwa","year":"2010","journal-title":"Circulation"},{"key":"2026080919292062500_jex146-B47","first-page":"1972","article-title":"Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography","volume":"33","author":"Kubota","year":"1992","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj2610211","article-title":"Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture","volume":"261","author":"Newsholme","year":"1989","journal-title":"Biochem J"},{"key":"2026080919292062500_jex146-B49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2967\/jnumed.112.105155","article-title":"SNMMI\/ASNC\/SCCT guideline for cardiac SPECT\/CT and PET\/CT 1.0","volume":"54","author":"Dorbala","year":"2013","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2967\/jnumed.112.112524","article-title":"EANM\/SNMMI guideline for 18F-FDG use in inflammation and infection","volume":"54","author":"Jamar","year":"2013","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B51","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/2191-219X-4-1","article-title":"Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis","volume":"4","author":"Morooka","year":"2014","journal-title":"EJNMMI Res"},{"key":"2026080919292062500_jex146-B52","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in (1)(8)F-FDG PET imaging","volume":"57","author":"Scholtens","year":"2015","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B53","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B54","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919292062500_jex146-B55","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by (1)(8)F- fluorodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","article-title":"Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis","volume":"16","author":"Langah","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B58","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B60","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s12350-014-9921-5","article-title":"Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"21","author":"Waller","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2026080919292062500_jex146-B62","first-page":"1675","article-title":"Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy","volume":"106","author":"Le","year":"1994","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B63","first-page":"1327","article-title":"Highlights from the updated joint ASNC\/SNMMI PET myocardial perfusion and metabolism clinical imaging guidelines","volume-title":"J Nucl Med","author":"Dilsizian","year":"2016"},{"key":"2026080919292062500_jex146-B64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12350-010-9246-y","article-title":"Single photon-emission computed tomography","volume":"17","author":"Holly","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B65","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s00259-016-3317-5","article-title":"Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)","volume":"43","author":"Sciagra","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919292062500_jex146-B66","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00259-015-3139-x","article-title":"EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT\/CT: 2015 revision","volume":"42","author":"Verberne","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919292062500_jex146-B67","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00259-002-0998-8","article-title":"A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study","volume":"29","author":"Kapur","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919292062500_jex146-B68","first-page":"2","article-title":"Scadding revisited: a proposed staging system for sardiac sarcoidosis","volume":"31","author":"Berman","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026080919292062500_jex146-B69","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919292062500_jex146-B70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"2026080919292062500_jex146-B71","article-title":"Isolated cardiac sarcoidosis: a focused review of an under-recognized entity","author":"Okada","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B72","first-page":"341","article-title":"Usefulness of 18F-FDG PET for diagnosis of cardiac sarcoidosis","volume":"36","author":"Okumura","year":"1999","journal-title":"Kaku Igaku"},{"key":"2026080919292062500_jex146-B73","doi-asserted-by":"crossref","first-page":"91.","DOI":"10.1186\/1532-429X-15-91","article-title":"Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update","volume":"15","author":"Kramer","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919292062500_jex146-B74","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and (18)F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080919292062500_jex146-B75","doi-asserted-by":"crossref","first-page":"35.","DOI":"10.1186\/1532-429X-10-35","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols","volume":"10","author":"Kramer","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919292062500_jex146-B76","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B77","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.14-0139","article-title":"Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation","volume":"146","author":"Nagai","year":"2014","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B78","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","article-title":"Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study","volume":"13","author":"Patel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080919292062500_jex146-B79","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1378\/chest.128.3.1629","article-title":"The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B80","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919292062500_jex146-B81","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","article-title":"Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function","volume":"28","author":"Watanabe","year":"2013","journal-title":"J Thorac Imaging"},{"key":"2026080919292062500_jex146-B82","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"2026080919292062500_jex146-B83","doi-asserted-by":"crossref","first-page":"e003738.","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B84","doi-asserted-by":"crossref","first-page":"e005001.","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B85","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9343(01)00677-5","article-title":"Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging","volume":"110","author":"Shimada","year":"2001","journal-title":"Am J Med"},{"key":"2026080919292062500_jex146-B86","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jmri.24196","article-title":"Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis","volume":"39","author":"Yang","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"2026080919292062500_jex146-B87","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.76.9.4275","article-title":"Leukotriene C: a slow-reacting substance from murine mastocytoma cells","volume":"76","author":"Murphy","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026080919292062500_jex146-B88","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1378\/chest.122.6.1895","article-title":"Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study","volume":"122","author":"Vignaux","year":"2002","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B89","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","journal-title":"Am Heart J"},{"key":"2026080919292062500_jex146-B90","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1378\/chest.90.4.528","article-title":"Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis","volume":"90","author":"Ratner","year":"1986","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B91","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"2026080919292062500_jex146-B92","first-page":"3","article-title":"Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy","volume":"29","author":"Nery","year":"2013","journal-title":"Can J Cardiol"},{"key":"2026080919292062500_jex146-B93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"Hamzeh","year":"2012","journal-title":"Chest"},{"key":"2026080919292062500_jex146-B94","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026080919292062500_jex146-B95","first-page":"634","article-title":"Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Nadel","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B96","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"2026080919292062500_jex146-B97","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026080919292062500_jex146-B98","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919292062500_jex146-B99","doi-asserted-by":"crossref","first-page":"e000867.","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of Known or Suspected Cardiac Sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919292062500_jex146-B100","first-page":"50","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026080919292062500_jex146-B101","doi-asserted-by":"crossref","first-page":"312.","DOI":"10.1093\/eurheartj\/eht335","article-title":"Utility of multimodal cardiac imaging with PET\/MRI in cardiac sarcoidosis: implications for diagnosis, monitoring and treatment","volume":"35","author":"Schneider","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919292062500_jex146-B102","article-title":"Simultaneous cardiac imaging to detect inflammation and scar tissue with F-fluorodeoxyglucose PET\/MRI in cardiac sarcoidosis","author":"Wada","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"2026080919292062500_jex146-B103","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/18\/10\/1073\/70577865\/ehjcimaging_18_10_1073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/18\/10\/1073\/70577865\/ehjcimaging_18_10_1073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:29:47Z","timestamp":1786318187000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/18\/10\/1073\/4344894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,1]]},"references-count":103,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,4]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jex146","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,10,1]]}}}